Cargando…
Identification of Periostin as a Critical Marker of Progression/Reversal of Hypertensive Nephropathy
Progression of chronic kidney disease (CKD) is a major health issue due to persistent accumulation of extracellular matrix in the injured kidney. However, our current understanding of fibrosis is limited, therapeutic options are lacking, and progressive degradation of renal function prevails in CKD...
Autores principales: | Guerrot, Dominique, Dussaule, Jean-Claude, Mael-Ainin, Mouna, Xu-Dubois, Yi-Chun, Rondeau, Eric, Chatziantoniou, Christos, Placier, Sandrine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293874/ https://www.ncbi.nlm.nih.gov/pubmed/22403621 http://dx.doi.org/10.1371/journal.pone.0031974 |
Ejemplares similares
-
Extracorporeal shock wave therapy does not improve hypertensive nephropathy
por: Caron, Jonathan, et al.
Publicado: (2016) -
Progression of renal fibrosis: the underestimated role of endothelial alterations
por: Guerrot, Dominique, et al.
Publicado: (2012) -
Searching novel diagnostic markers and targets for therapy of CKD
por: Kavvadas, Panos, et al.
Publicado: (2014) -
Role of Periostin and Nuclear Factor-κB Interplay in the Development of Diabetic Nephropathy
por: Abbad, Lilia, et al.
Publicado: (2022) -
Periostin and Discoidin Domain Receptor 1: New Biomarkers or Targets for Therapy of Renal Disease
por: Prakoura, Niki, et al.
Publicado: (2017)